Published in Nat Rev Endocrinol on February 01, 2011
Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol (2012) 1.87
Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab (2012) 1.64
Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol (2013) 1.61
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig (2012) 1.30
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia. Mol Psychiatry (2016) 1.19
Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism (2011) 1.17
The emerging role of dietary fructose in obesity and cognitive decline. Nutr J (2013) 1.05
Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care (2012) 1.05
Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol (2014) 1.01
Neural circuitry and immunity. Immunol Res (2015) 0.97
Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am (2012) 0.95
Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab (Seoul) (2014) 0.93
Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment. Clin Interv Aging (2015) 0.93
Type 2 diabetes and cognitive impairment: contributions from neuroimaging. J Geriatr Psychiatry Neurol (2014) 0.92
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes. Korean J Intern Med (2014) 0.88
IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults. Neurobiol Aging (2013) 0.87
The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2014) 0.86
Optimal therapy of type 2 diabetes: a controversial challenge. Aging (Albany NY) (2014) 0.85
Cognitive functions in middle aged individuals are related to metabolic disturbances and aerobic capacity: a cross-sectional study. PLoS One (2012) 0.85
The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control. Am J Geriatr Psychiatry (2014) 0.85
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group. Diabetes Technol Ther (2014) 0.85
Racial/ethnic differences in dementia risk among older type 2 diabetic patients: the diabetes and aging study. Diabetes Care (2013) 0.84
Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes. PLoS One (2014) 0.84
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease? Int J Alzheimers Dis (2012) 0.82
Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol Med (2015) 0.82
Diabetes is associated with lower global cognitive function in schizophrenia. Schizophr Res (2012) 0.81
Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine. Int J Endocrinol (2015) 0.80
Impaired glucose regulation is associated with poorer performance on the Stroop Task. Physiol Behav (2013) 0.80
Treadmill exercise decreases incidence of Alzheimer's disease by suppressing glycogen synthase kinase-3β expression in streptozotocin-induced diabetic rats. J Exerc Rehabil (2015) 0.80
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta (2016) 0.80
Impact of family support improvement behaviors on anti diabetic medication adherence and cognition in type 2 diabetic patients. J Diabetes Metab Disord (2014) 0.79
Diabetes. Cognitive decline and T2DM--a disconnect in the evidence? Nat Rev Endocrinol (2014) 0.79
Diabetes and the elderly brain: sweet memories? Ther Adv Endocrinol Metab (2012) 0.79
Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice. Sci Rep (2014) 0.79
Sex hormone binding globulin and verbal memory in older men. Am J Geriatr Psychiatry (2013) 0.79
Insulin and sex interactions in older adults with mild cognitive impairment. J Alzheimers Dis (2012) 0.79
Polychlorinated biphenyl exposures and cognition in older U.S. adults: NHANES (1999-2002). Environ Health Perspect (2013) 0.78
Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model. PLoS One (2014) 0.78
Relationship between blood levels of methyl donor and folate and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study. J Clin Biochem Nutr (2014) 0.78
Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study. Alzheimer Dis Assoc Disord (2016) 0.78
Cognitive impairment, oral self-care function and dental caries severity in community-dwelling older adults. Gerodontology (2013) 0.78
Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome. Cardiovasc Psychiatry Neurol (2014) 0.78
The unfolded protein response to endoplasmic reticulum stress in cultured astrocytes and rat brain during experimental diabetes. Neurochem Int (2013) 0.78
E3 ubiquitin ligase Siah-1 downregulates synaptophysin expression under high glucose and hypoxia. Am J Transl Res (2015) 0.78
'Patient-centered care' for complex patients with type 2 diabetes mellitus-analysis of two cases. Clin Med Insights Endocrinol Diabetes (2013) 0.77
Effects of Comorbid Depression and Diabetes Mellitus on Cognitive Decline in Older Mexican Americans. J Am Geriatr Soc (2016) 0.77
Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes. Diabetologia (2014) 0.77
[Diabetes and dementia]. Z Gerontol Geriatr (2012) 0.77
Assessing the genetic overlap between BMI and cognitive function. Mol Psychiatry (2016) 0.77
Obesity and sex interact in the regulation of Alzheimer's disease. Neurosci Biobehav Rev (2015) 0.76
The human brain produces fructose from glucose. JCI Insight (2017) 0.76
Fasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders. J Biol Chem (2015) 0.76
Neural stem cells in the diabetic brain. Stem Cells Int (2012) 0.76
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study. EBioMedicine (2016) 0.75
Simple self-reported behavioral or psychological characteristics as risk factors for future type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 14. J Diabetes Investig (2014) 0.75
F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline. Diabetes (2016) 0.75
Association of Increased Serum ACE Activity with Logical Memory Ability in Type 2 Diabetic Patients with Mild Cognitive Impairment. Front Behav Neurosci (2016) 0.75
Memory is preserved in older adults taking AT1 receptor blockers. Alzheimers Res Ther (2017) 0.75
Multimodal MRI for early diabetic mild cognitive impairment: study protocol of a prospective diagnostic trial. BMC Med Imaging (2016) 0.75
Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models. Neurogenesis (Austin) (2017) 0.75
Cognitive status and foot self care practice in overweight diabetics, engaged in different levels of physical activity. J Diabetes Metab Disord (2014) 0.75
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus. Diabetes Metab J (2016) 0.75
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study. Biomed Res Int (2016) 0.75
Serum Soluble Adhesion Molecules and Markers of Systemic Inflammation in Elderly Diabetic Patients with Mild Cognitive Impairment and Depressive Symptoms. Biomed Res Int (2015) 0.75
Glycemic control, cognitive function, and family support among middle-aged and older Hispanics with diabetes: The Hispanic Community Health Study/Study of Latinos. Diabetes Res Clin Pract (2016) 0.75
Blood pressure levels and prognosis of intracranial trauma patients with cognitive dysfunction. Pak J Med Sci (2014) 0.75
Aberrant Brain Regional Homogeneity and Functional Connectivity in Middle-Aged T2DM Patients: A Resting-State Functional MRI Study. Front Hum Neurosci (2016) 0.75
Cognition in Adults and Older Adults With Type 1 Diabetes: Chicken or Egg? Diabetes Spectr (2016) 0.75
Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice. J Cereb Blood Flow Metab (2015) 0.75
The association between cognitive decline and incident depressive symptoms in a sample of older Puerto Rican adults with diabetes. Int Psychogeriatr (2017) 0.75
Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats. Med Sci Monit (2017) 0.75
Dietary glycaemic load associated with cognitive performance in elderly subjects. Eur J Nutr (2014) 0.75
The role of melatonin in the onset and progression of type 3 diabetes. Mol Brain (2017) 0.75
Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease. Exp Biol Med (Maywood) (2017) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res (2002) 22.73
Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol (2006) 6.97
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA (2004) 4.73
Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med (2007) 4.65
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A (1993) 2.79
The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev (2005) 2.74
Statins for the prevention of dementia. Cochrane Database Syst Rev (2009) 2.38
Cognitive function and blood rheology: results from the Caerphilly cohort of older men. Age Ageing (2001) 2.32
Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care (1997) 2.04
Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care (2007) 1.97
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia (2009) 1.96
Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream. PLoS Med (2008) 1.95
Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc (2007) 1.91
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ (2008) 1.77
Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care (2004) 1.71
Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care (2007) 1.61
Brain aging correlates: retardation by hormonal-pharmacological treatments. Science (1981) 1.61
Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res (2009) 1.60
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol (2007) 1.60
Age changes in processing speed as a leading indicator of cognitive aging. Psychol Aging (2007) 1.59
Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. J Clin Endocrinol Metab (2001) 1.58
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev (2009) 1.56
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A (2004) 1.52
Hippocampal aging and adrenocorticoids: quantitative correlations. Science (1978) 1.50
Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.50
Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc (2007) 1.46
Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des (2005) 1.44
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke (2005) 1.42
Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci (1999) 1.40
Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci (2008) 1.34
Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34
Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab (2007) 1.33
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2010) 1.32
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
Stress and the aging hippocampus. Front Neuroendocrinol (1999) 1.26
Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator. Diabetes Care (2007) 1.24
Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother (2009) 1.21
Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology (2005) 1.21
Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia (2009) 1.19
Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) (2005) 1.17
Subtle and obvious keys for the Minnesota multiphasic personality inventory. J Consult Psychol (1948) 1.17
11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology (1990) 1.14
The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol (2006) 1.14
C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med (2004) 1.13
Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol (2008) 1.13
Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol (2006) 1.12
Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J Clin Endocrinol Metab (2010) 1.11
Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care (1999) 1.11
Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men. J Clin Endocrinol Metab (2009) 1.11
Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients. Eur J Endocrinol (2006) 1.10
Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med (2009) 1.07
Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry (1996) 1.02
Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol (2000) 0.99
Severe hypoglycaemia and cognitive impairment in diabetes. BMJ (1996) 0.99
Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosom Med (2009) 0.99
Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. J Clin Endocrinol Metab (2001) 0.99
Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet (1988) 0.98
Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol (1995) 0.97
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia (2009) 0.94
Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J Neurosci (2002) 0.94
Glucocorticoid receptor polymorphisms in major depression. Focus on glucocorticoid sensitivity and neurocognitive functioning. Ann N Y Acad Sci (2009) 0.94
Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry (1984) 0.93
Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis (2001) 0.91
Hypercortisolism in diabetes mellitus. Diabetes Care (1988) 0.89
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care (2010) 0.88
Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatry (1984) 0.88
The interaction of depression and diabetes: a review. Curr Diabetes Rev (2007) 0.80
Salivary cortisol day profiles in elderly with mild cognitive impairment. Psychoneuroendocrinology (2002) 0.80
Is sticky blood a treatable determinant of cognitive decline and of dementia? Age Ageing (2001) 0.79
Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study. J Neurol Neurosurg Psychiatry (2007) 0.78
Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study. Age Ageing (2010) 0.77
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA (2010) 5.10
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet (2012) 4.85
Age-associated cognitive decline. Br Med Bull (2009) 2.26
Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction (2010) 2.01
Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
The risk of maternal obesity to the long-term health of the offspring. Clin Endocrinol (Oxf) (2013) 1.40
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2010) 1.32
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
The consequences of obesity and excess weight gain in pregnancy. Proc Nutr Soc (2011) 1.14
Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes (2012) 1.13
Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J (2012) 1.12
Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men. J Clin Endocrinol Metab (2009) 1.11
The relationship between type 2 diabetes and dementia. Br Med Bull (2008) 1.08
Association of KIBRA and memory. Neurosci Lett (2009) 1.05
An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth. Clin Endocrinol (Oxf) (2012) 1.04
Relationship between lifetime smoking, smoking status at older age and human cognitive function. Neuroepidemiology (2005) 1.03
Diabetes, cognitive impairment, and dementia. BMJ (2008) 1.03
Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosom Med (2009) 0.99
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol (2010) 0.99
Changes in ankle brachial index in symptomatic and asymptomatic subjects in the general population. J Vasc Surg (2003) 0.98
Variation in the uric acid transporter gene (SLC2A9) and memory performance. Hum Mol Genet (2010) 0.97
Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: influences on maternal and fetal outcomes. Neuroendocrinology (2013) 0.96
Home blood glucose monitoring in type 2 diabetes. BMJ (2004) 0.95
Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol (2005) 0.94
Carotid intima-media thickness and the prediction of vascular events. Vasc Med (2012) 0.93
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2013) 0.91
The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes Metab (2009) 0.91
Glucocorticoids turn over slowly in human adipose tissue in vivo. J Clin Endocrinol Metab (2010) 0.90
Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro. Endocrinology (2010) 0.89
Intelligence and persisting with medication for two years: Analysis in a randomised controlled trial. Intelligence (2009) 0.89
Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia. Clin Endocrinol (Oxf) (2012) 0.89
Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn (2009) 0.89
Epigenetic Signatures of Cigarette Smoking. Circ Cardiovasc Genet (2016) 0.88
C-reactive protein, APOE genotype and longitudinal cognitive change in an older population. Age Ageing (2013) 0.87
Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes (2012) 0.87
Association between polymorphisms of the dopamine receptor D2 and catechol-o-methyl transferase genes and cognitive function. Behav Genet (2010) 0.87
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). BMC Med Res Methodol (2013) 0.87
No association between Cholinergic Muscarinic Receptor 2 (CHRM2) genetic variation and cognitive abilities in three independent samples. Behav Genet (2009) 0.86
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study. J Hypertens (2013) 0.86
Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. Hypertension (2014) 0.85
Serum leptin and cognitive function in people with type 2 diabetes. Neurobiol Aging (2012) 0.85
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS One (2012) 0.84
Skeletal muscle glucocorticoid receptor density and insulin resistance. JAMA (2002) 0.83
Associations between maternal level of education and occupational status with placental glucocorticoid regeneration and sensitivity. Clin Endocrinol (Oxf) (2014) 0.82
Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study. Psychosom Med (2011) 0.82
Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circ Cardiovasc Genet (2015) 0.82
Mechanisms linking in utero stress to altered offspring behaviour. Curr Top Behav Neurosci (2014) 0.81
Ankle--brachial index predicts level of, but not change in, cognitive function: the Edinburgh Artery Study at the 15-year follow-up. Vasc Med (2010) 0.81
Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2013) 0.81
Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology (2013) 0.81
Antenatal glucocorticoid treatment: are we doing harm to term babies? J Clin Endocrinol Metab (2012) 0.80
Placental 5-methylcytosine and 5-hydroxymethylcytosine patterns associate with size at birth. Epigenetics (2015) 0.79
Productivity cost model of the treatment of rheumatoid arthritis with abatacept. J Med Econ (2008) 0.78
Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults. Psychosom Med (2015) 0.77
Evaluation of an FFQ to assess total energy and nutrient intakes in severely obese pregnant women. Public Health Nutr (2012) 0.77
Increased morning adrenocorticotrophin hormone (ACTH) levels in women with postpartum thoughts of harming the infant. Psychoneuroendocrinology (2010) 0.76
A gene-centric study of common carotid artery remodelling. Atherosclerosis (2012) 0.76
Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.75
Leptin, somatic depressive symptoms and the metabolic syndrome: a comment on Chirinos et al. Ann Behav Med (2013) 0.75
Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis. Circ Cardiovasc Genet (2016) 0.75
Maternal Licorice Consumption During Pregnancy and Pubertal, Cognitive, and Psychiatric Outcomes in Children. Am J Epidemiol (2017) 0.75
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Liver Int (2013) 0.75
The epigenetic clock and telomere length are independently associated with chronological age and mortality. Int J Epidemiol (2017) 0.75
Intergenerational Transmission of Birth Weight Across Three Generations. Am J Epidemiol (2017) 0.75
New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals. Circ Cardiovasc Genet (2017) 0.75
Räikkönen et al. Respond to "Maternal Stress and Offspring Health". Am J Epidemiol (2017) 0.75